{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:53:54Z","timestamp":1791291234136,"version":"4.3.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.clinthera.2011.10.008","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T04:10:08Z","timestamp":1321935008000},"page":"1547-1559","source":"Crossref","is-referenced-by-count":40,"title":["Denosumab for the Reduction of Bone Loss in Postmenopausal Osteoporosis: A Review"],"prefix":"10.1016","volume":"33","author":[{"given":"Mary Barna","family":"Bridgeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolee","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2011.10.008_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/gme.0b013e3181c617e6","article-title":"The management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society","volume":"17","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.clinthera.2011.10.008_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1359\/jbmr.090706","article-title":"Prevalence and trends in low femur bone density among older US adults: NHANES 2005\u20132006 compared with NHANES III","volume":"20","author":"Looker","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.clinthera.2011.10.008_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1359\/jbmr.1997.12.1.16","article-title":"Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation","volume":"12","author":"Melton","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.clinthera.2011.10.008_bib5","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1359\/jbmr.1998.13.12.1915","article-title":"Bone density and fracture risk in men","volume":"13","author":"Melton","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.clinthera.2011.10.008_bib6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF01622200","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report","volume":"4","author":"Kanis","year":"1994","journal-title":"Osteoporos Int"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2011.10.008_bib8","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.2146\/ajhp100076","article-title":"Managing osteoporosis in postmenopausal women","volume":"67","author":"Vondraneck","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.clinthera.2011.10.008_bib9","series-title":"Fosamax (alendronate sodium) [prescribing information]","year":"2010"},{"key":"10.1016\/j.clinthera.2011.10.008_bib10","series-title":"Boniva (ibandronate sodium) [prescribing information]","year":"2010"},{"key":"10.1016\/j.clinthera.2011.10.008_bib11","series-title":"Actonel (risedronate sodium) [prescribing information]","year":"2010"},{"key":"10.1016\/j.clinthera.2011.10.008_bib12","series-title":"Reclast (zoledronic acid) [prescribing information]","year":"2010"},{"key":"10.1016\/j.clinthera.2011.10.008_bib14","series-title":"Miacalcin (calcitonin salmon) [prescribing information]","year":"2006"},{"key":"10.1016\/j.clinthera.2011.10.008_bib15","series-title":"Fortical (calcitonin-salmon [rDNA origin]) [prescribing information]","year":"2010"},{"key":"10.1016\/j.clinthera.2011.10.008_bib16","series-title":"Forteo (teriparatide [rDNA origin] injection) [prescribing information]","year":"2010"},{"key":"10.1016\/j.clinthera.2011.10.008_bib17","series-title":"Prolia (denosumab) [prescribing information]","year":"2010"},{"key":"10.1016\/j.clinthera.2011.10.008_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/er.21.2.115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.clinthera.2011.10.008_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11914-009-0004-5","article-title":"Denosumab: anti-RANKL antibody","volume":"7","author":"Miller","year":"2009","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.clinthera.2011.10.008_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.clinthera.2011.10.008_bib21","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women","volume":"111","author":"Eghbali-Fatourechi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2011.10.008_bib22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular disease","volume":"292","author":"Hofbauer","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2011.10.008_bib23","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1158\/1078-0432.CCR-05-1933","article-title":"A study of the biological receptor activator of nuclear factor K-B ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastasis from breast cancer","volume":"12","author":"Body","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clinthera.2011.10.008_bib24","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women","volume":"19","author":"Bekker","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.clinthera.2011.10.008_bib25","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2011.10.008_bib26","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1359\/jbmr.070809","article-title":"Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD","volume":"22","author":"Lewiecki","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.clinthera.2011.10.008_bib27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2008.04.007","article-title":"Effect of denosumab on bone density and turnover in post menopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial","volume":"43","author":"Miller","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.clinthera.2011.10.008_bib28","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1210\/jc.2007-2814","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women","volume":"93","author":"Bone","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2011.10.008_bib29","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2011.10.008_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1359\/jbmr.0809010","article-title":"Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial","volume":"24","author":"Brown","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.clinthera.2011.10.008_bib31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1359\/jbmr.090716","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy","volume":"25","author":"Kendler","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.clinthera.2011.10.008_bib32","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1310\/hpj4510-785","article-title":"Denosumab","volume":"45","author":"Cada","year":"2010","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.clinthera.2011.10.008_bib33","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","article-title":"Osteonecrosis of the jaw in a patient on denosumab","volume":"68","author":"Aghaloo","year":"2010","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811006837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811006837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T04:23:10Z","timestamp":1543378990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811006837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0149291811006837"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.10.008","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}